Absorption Systems has been awarded a 2-year contract for a total amount of approximately $300,000 by the U.S. Food and Drug Administration (FDA). The funding mechanism is a Broad Agency Announcement, or BAA. The ultimate goal is to streamline FDA approval of generic versions of orally administered drugs.   Under the terms of the contract, Absorption Systems will use its proprietary In Vitro Dissolution Absorption System (IDAS) to evaluate the effects of excipients (inactive ingredients in a fin...